Equities

Gohealth Inc

GOCO:NAQ

Gohealth Inc

Actions
FinancialsNon-life Insurance
  • Price (USD)10.07
  • Today's Change0.00 / 0.00%
  • Shares traded26.12k
  • 1 Year change-30.55%
  • Beta1.6579
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy1
Outperform1
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The 3 analysts offering 12 month price targets for GoHealth Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 13.00. The median estimate represents a 80.00% increase from the last price of 10.00.
High120.0%22.00
Med80.0%18.00
Low30.0%13.00

Earnings history & estimates in USD

On Aug 08, 2024, GoHealth Inc reported 2nd quarter 2024 losses of -2.70 per share.
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate-105.15%
GoHealth Inc reported annual 2023 losses of -7.19 per share on Mar 14, 2024.
Average growth rate+59.42%
More ▼

Revenue history & estimates in USD

GoHealth Inc had 2nd quarter 2024 revenues of 105.87m. This missed the 141.79m consensus estimate of the 4 analysts following the company. This was 42.20% below the prior year's 2nd quarter results.
Average growth rate+6.54%
GoHealth Inc had revenues for the full year 2023 of 734.67m. This was 19.03% below the prior year's results.
Average growth rate-4.18%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.